Loading...
Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect
The histone deacetylase inhibitors (HDACi) have demonstrated anticancer efficacy across a range of malignancies, most impressively in the hematological cancers. It is uncertain whether this clinical efficacy is attributable predominantly to their ability to induce apoptosis and differentiation in th...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer US
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3003794/ https://ncbi.nlm.nih.gov/pubmed/21161327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-010-9596-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|